BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32134675)

  • 21. Spherical crystallization of mebendazole to improve processability.
    Kumar S; Chawla G; Bansal AK
    Pharm Dev Technol; 2008; 13(6):559-68. PubMed ID: 18720249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets.
    Ali R; Dashevsky A; Bodmeier R
    Int J Pharm; 2017 Jan; 516(1-2):3-8. PubMed ID: 27818241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dependence of Punch Sticking on Compaction Pressure-Roles of Particle Deformability and Tablet Tensile Strength.
    Paul S; Wang K; Taylor LJ; Murphy B; Krzyzaniak J; Dawson N; Mullarney MP; Meenan P; Sun CC
    J Pharm Sci; 2017 Aug; 106(8):2060-2067. PubMed ID: 28478129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological and Physicochemical Evaluation of Two Distinct Glibenclamide/Hypromellose Amorphous Nanoparticles Prepared by the Antisolvent Method.
    Yonashiro H; Higashi K; Morikawa C; Ueda K; Itoh T; Ito M; Masu H; Noguchi S; Moribe K
    Mol Pharm; 2018 Apr; 15(4):1587-1597. PubMed ID: 29502422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Definition of a solvent system for spherical crystallization of salbutamol sulfate by quasi-emulsion solvent diffusion (QESD) method.
    Nocent M; Bertocchi L; Espitalier F; Baron M; Couarraze G
    J Pharm Sci; 2001 Oct; 90(10):1620-7. PubMed ID: 11745720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Particle design of tolbutamide by the spherical crystallization technique. III. Micromeritic properties and dissolution rate of tolbutamide spherical agglomerates prepared by the quasi-emulsion solvent diffusion method and the solvent change method.
    Sano A; Kuriki T; Kawashima Y; Takeuchi H; Hino T; Niwa T
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):733-9. PubMed ID: 2347016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation.
    Van Eerdenbrugh B; Taylor LS
    Mol Pharm; 2010 Aug; 7(4):1328-37. PubMed ID: 20536263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
    Khanvilkar KH; Huang Y; Moore AD
    Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward a Molecular Understanding of the Impact of Crystal Size and Shape on Punch Sticking.
    Paul S; Taylor LJ; Murphy B; Krzyzaniak JF; Dawson N; Mullarney MP; Meenan P; Sun CC
    Mol Pharm; 2020 Apr; 17(4):1148-1158. PubMed ID: 32058728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Worsened punch sticking by external lubrication with magnesium stearate.
    Xiang T; Sun CC
    Int J Pharm; 2024 Jan; 649():123636. PubMed ID: 38013042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Particle Surface Area and Adhesion Force in the Sticking Behavior of Pharmaceutical Powders.
    Capece M
    J Pharm Sci; 2019 Dec; 108(12):3803-3813. PubMed ID: 31473214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of orodispersible polymer films with focus on the solid state characterization of crystalline loperamide.
    Woertz C; Kleinebudde P
    Eur J Pharm Biopharm; 2015 Aug; 94():52-63. PubMed ID: 25976316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
    Park JB; Lim J; Kang CY; Lee BJ
    Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions.
    Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S
    Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of pH on the stabilization and digestive characteristics of soybean lipophilic protein oil-in-water emulsions with hypromellose.
    Li Y; Zhong M; Xie F; Sun Y; Zhang S; Qi B
    Food Chem; 2020 Mar; 309():125579. PubMed ID: 31683149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gelatin-hydroxypropyl methylcellulose water-in-water emulsions as a new bio-based packaging material.
    Esteghlal S; Niakosari M; Hosseini SM; Mesbahi GR; Yousefi GH
    Int J Biol Macromol; 2016 May; 86():242-9. PubMed ID: 26808017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.
    Bochmann ES; Neumann D; Gryczke A; Wagner KG
    Eur J Pharm Biopharm; 2019 Aug; 141():111-120. PubMed ID: 31100430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.